Inovio Pharmaceuticals
INO
INO
211 hedge funds and large institutions have $682M invested in Inovio Pharmaceuticals in 2021 Q2 according to their latest regulatory filings, with 41 funds opening new positions, 68 increasing their positions, 46 reducing their positions, and 47 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
less call options, than puts
Call options by funds: $ | Put options by funds: $
3% less funds holding
Funds holding: 218 → 211 (-7)
13% less first-time investments, than exits
New positions opened: 41 | Existing positions closed: 47
Holders
211
Holding in Top 10
–
Calls
$33.9M
Puts
$37.2M
Top Buyers
| 1 | +$17.2M | |
| 2 | +$10.9M | |
| 3 | +$9.7M | |
| 4 |
BlackRock
New York
|
+$6.09M |
| 5 |
State Street
Boston,
Massachusetts
|
+$6.04M |
Top Sellers
| 1 | -$37.2M | |
| 2 | -$29M | |
| 3 | -$7.28M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$5.01M |
| 5 |
California Public Employees Retirement System
Sacramento,
California
|
-$2.96M |